Recordati SpA engages in the research, development, manufacturing and marketing of pharmaceuticals. It operates through the following segments: Pharmaceutical and Rare Diseases. The Pharmaceutical segment offers prescription and over-the-counter products as well as chemical syntheses, intermediates, and active ingredients for its proprietary and licensed brands. The Rare Diseases segment develops, produces, and sells orphan drugs for the treatment of uncommon metabolic deficiencies of a genetic nature. Recordati was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.